Personal tools
Home > News & Events > News > Buck Institute: "Global Leader in Revolutionary Stem Cell Technology"
Document Actions

Buck Institute: "Global Leader in Revolutionary Stem Cell Technology"

Associate Professor, Xianmin Zeng PhD, from the Buck Institute and a LLHF Grant recipient has developed new stem cell therapy for Parkinson's Disease which provides a method to reproduce the required amount of clinical grade neurons essential for human trials. She also confirmed this technique could be created in a good manufacturing practice facility which is necessary for clinical trials.

Over the last year Dr. Zeng has been traveling around the world to help other countries coordinate stem cell manufacturing procedures as well.

"The global collaboration we are doing will get others the tools they need so that they don't have to start from the beginning. This should speed up the search for new therapies."


Read the full article in the Buck Institute's 2012 Annual Report

Find out more about Dr. Xianmin Zeng's research at the Buck Institute

Read Dr. Zeng's LLHF Research Abstract



Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: